Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Int J Mol Sci ; 20(5)2019 Feb 26.
Artículo en Inglés | MEDLINE | ID: mdl-30813528

RESUMEN

Glucocorticoids are used during prostate cancer (PCa) treatment. However, they may also have the potential to drive castration resistant prostate cancer (CRPC) growth via the glucocorticoid receptor (GR). Given the association between inflammation and PCa, and the anti-inflammatory role of heme oxygenase 1 (HO-1), we aimed at identifying the molecular processes governed by the interaction between HO-1 and GR. PCa-derived cell lines were treated with Hemin, Dexamethasone (Dex), or both. We studied GR gene expression by RTqPCR, protein expression by Western Blot, transcriptional activity using reporter assays, and nuclear translocation by confocal microscopy. We also evaluated the expression of HO-1, FKBP51, and FKBP52 by Western Blot. Hemin pre-treatment reduced Dex-induced GR activity in PC3 cells. Protein levels of FKBP51, a cytoplasmic GR-binding immunophilin, were significantly increased in Hemin+Dex treated cells, possibly accounting for lower GR activity. We also evaluated these treatments in vivo using PC3 tumors growing as xenografts. We found non-significant differences in tumor growth among treatments. Immunohistochemistry analyses revealed strong nuclear GR staining in almost all groups. We did not observe HO-1 staining in tumor cells, but high HO-1 reactivity was detected in tumor infiltrating macrophages. Our results suggest an association and crossed modulation between HO-1 and GR pathways.


Asunto(s)
Hemo-Oxigenasa 1/metabolismo , Neoplasias de la Próstata/metabolismo , Receptores de Glucocorticoides/metabolismo , Animales , Línea Celular Tumoral , Dexametasona/farmacología , Supervivencia sin Enfermedad , Hemo-Oxigenasa 1/genética , Hemina/farmacología , Humanos , Masculino , Ratones , Regiones Promotoras Genéticas/genética , Elementos de Respuesta/genética , Transducción de Señal , Proteínas de Unión a Tacrolimus/metabolismo , Ensayos Antitumor por Modelo de Xenoinjerto
2.
J Biochem Mol Toxicol ; 30(8): 404-13, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27044015

RESUMEN

Glyphosate-based herbicides (GF) are extensively used for weed control. Thus, it is important to investigate their putative toxic effects. We have reported that GF at subagriculture concentrations inhibits proliferation and differentiation to adipocytes of 3T3-L1 fibroblasts. In this investigation, we evaluated the effect of GF on genes upregulated during adipogenesis. GF was able to inhibit the induction of PPAR gamma, the master gene in adipogenesis but not C/EBP beta, which precedes PPAR gamma activation. GF also inhibited differentiation and proliferation of another model of preadipocyte: mouse embryonic fibroblasts. In exponentially growing 3T3-L1 cells, GF increased lipid peroxidation and the activity of the antioxidant enzyme, superoxide dismutase. We also found that proliferation was inhibited with lower concentrations of GF when time of exposure was extended. Thus, GF was able to inhibit proliferation and differentiation of preadipocytes and to induce oxidative stress, which is indicative of its ability to alter cellular physiology.


Asunto(s)
Adipocitos/efectos de los fármacos , Adipogénesis/efectos de los fármacos , Fibroblastos/efectos de los fármacos , Glicina/análogos & derivados , Herbicidas/farmacología , PPAR gamma/genética , Células 3T3-L1 , Adipocitos/citología , Adipocitos/metabolismo , Animales , Proteína beta Potenciadora de Unión a CCAAT/genética , Proteína beta Potenciadora de Unión a CCAAT/metabolismo , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Embrión de Mamíferos , Fibroblastos/citología , Fibroblastos/metabolismo , Regulación de la Expresión Génica , Glicina/farmacología , Peroxidación de Lípido/efectos de los fármacos , Ratones , Estrés Oxidativo , PPAR gamma/antagonistas & inhibidores , PPAR gamma/metabolismo , Cultivo Primario de Células , Transducción de Señal , Superóxido Dismutasa/genética , Superóxido Dismutasa/metabolismo , Glifosato
3.
Dev Growth Differ ; 56(2): 143-51, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24444094

RESUMEN

Adipogenesis is stimulated in 3T3-L1 fibroblasts by a combination of insulin, dexamethasone and isobutylmethylxanthine, IBMX, (I+D+M). Two transcription factors are important for the acquisition of the adipocyte phenotype, C/EBP beta (CCAT enhancer-binding protein beta) and PPAR gamma (peroxisome proliferator-activated receptor gamma). IBMX increases cAMP content, which can activate protein kinase A (PKA) and/or EPAC (exchange protein activated by cAMP). To investigate the importance of IBMX in the differentiation mixture, we first evaluated the effect of the addition of IBMX on the increase of C/EBP beta and PPAR gamma and found an enhancement of the amount of both proteins. IBMX addition (I+D+M) or its replacement with a cAMP analogue, dibutyryl-cAMP or 8-(4-chlorophenylthio)-2-O'-methyl-cAMP (8CPT-2-Me-cAMP), the latter activates EPAC and not PKA, remarkably increased PPAR gamma mRNA. However, neither I+D nor any of the inducers alone, increased PPAR gamma mRNA to a similar extent, suggesting the importance of the presence of both IBMX and I+D. It was also found that the addition of IBMX or 8CPT-2-Me-cAMP was able to increase the content of C/EBP beta with respect to I+D. In agreement with these findings, a microarray analysis showed that the presence of either 8CPT-2-Me-cAMP or IBMX in the differentiation mixture was able to upregulate PPAR gamma and PPAR gamma-activated genes as well as other genes involved in lipid metabolism. Our results prove the involvement of IBMX-cAMP-EPAC in the regulation of adipogenic genes during differentiation of 3T3-L1 fibroblasts and therfore contributes to elucidate the role of cyclic AMP in this process.


Asunto(s)
Adipogénesis/genética , Diferenciación Celular/fisiología , AMP Cíclico/metabolismo , Regulación de la Expresión Génica/fisiología , Factores de Intercambio de Guanina Nucleótido/metabolismo , 1-Metil-3-Isobutilxantina/metabolismo , Células 3T3-L1 , Adipogénesis/fisiología , Análisis de Varianza , Animales , Compuestos Azo , Western Blotting , Proteína beta Potenciadora de Unión a CCAAT/metabolismo , Recuento de Células , Cartilla de ADN/genética , Dexametasona/metabolismo , Insulina/metabolismo , Ratones , Análisis por Micromatrices , Microscopía Fluorescente , PPAR gamma/metabolismo
4.
Toxicol In Vitro ; 28(4): 700-6, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24576443

RESUMEN

Heavy metals contamination has become an important risk factor for public health and the environment. Chromium is a frequent industrial contaminant and is also used in orthopaedic joint replacements made from cobalt-chromium-alloy. Since hexavalent chromium (Cr(VI)) was reported as genotoxic and carcinogenic in different mammals, to further evaluate its cytotoxicity, we investigated the effect of this heavy metal in the proliferation and differentiation to adipocytes of 3T3-L1 fibroblasts. These cells, after the addition of a mixture containing insulin, dexamethasone and methylisobutylxanthine, first proliferate, a process known as mitotic clonal expansion (MCE), and then differentiate to adipocytes. In this differentiation process a key transcription factor is induced: peroxisome proliferator-activated receptor gamma (PPAR gamma). We found that treatment of 3T3-L1 fibroblasts with potassium chromate inhibited proliferation in exponentially growing cells and MCE as well as differentiation. A decrease in PPAR gamma content, evaluated by western blot and immunofluorescence, was found in cells differentiated in the presence of chromium. On the other hand, after inhibition of differentiation with chromium, when the metal was removed, differentiation was recovered, which indicates that this may be a reversible effect. We also found an increase in the number of micronucleated cells after treatment with Cr(VI) which is associated with genotoxic effects. According to our results, Cr(VI) is able to inhibit proliferation and differentiation to adipocytes of 3T3-L1 fibroblasts and to increase micronucleated cells, which are all indicative of alterations in cellular physiology and therefore, contributes to further elucidate the cytotoxic effects of this heavy metal.


Asunto(s)
Adipocitos/citología , Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Cromo/toxicidad , Fibroblastos/efectos de los fármacos , Células 3T3-L1 , Adipocitos/efectos de los fármacos , Animales , Contaminantes Ambientales/toxicidad , Fibroblastos/citología , Fibroblastos/fisiología , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA